Just reported
From Teladoc Health's results release of 2026年10月28日; its quarterly report has since been filed.
Actual
$605.1M
-3.4% y/y
-0.3% q/q
Guided
$589M
midpoint
Actual
-$0.15
Guided
—
No guide given
Actual
-$28.1M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Teladoc Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
売上構成比はthree months ended June 30, 2026の推計であり、提出された報告書の数字ではありません。
Teladoc virtual care
Remote primary, urgent, mental health and specialty care, including expert second opinions.
Chronic care programs
Programs that help people manage ongoing conditions such as diabetes, using coaching, connected devices and clinical support.
BetterHelp
Online counseling and therapy through a network of licensed clinicians, using web, mobile app, phone and text.
BetterSleep
An app with tools intended to help users improve sleep and well-being.
Prism
Software used by Teladoc clinicians and coaches to provide and coordinate virtual care.
Solo and Inpatient Connected Care
Hospital telehealth systems that support remote patient visits and monitoring, using software and, where needed, equipment such as cameras, tablets and patient-room devices.
Teladoc connects people with clinicians by video, phone, app and messaging, and supplies hospitals with software and devices for virtual visits and patient monitoring. Employers and health insurers commonly pay monthly for access for covered workers or members; people can also pay per visit. BetterHelp connects individuals with licensed therapists online, with payment made out of pocket or through insurance. Teladoc completed 17.1 million virtual visits (2025, high) and had 100.3 million U.S. Integrated Care members (June 30, 2026, high).
Teladoc Health, Inc. 自身が米国証券取引委員会(SEC)に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
$8.79+1.0%11月13日 終値
2026年9月30日までの数値(2026年10月29日提出の10-Qより)
Teladoc sells virtual medical care to employers, health insurers and hospitals, and online therapy to individuals.
会社予想:2026会計年度の売上高$2.4B〜$2.4B — 前年同期比4.4%減(前年は$2.5B)
Grade F
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Teladoc Health, Inc. の評価履歴 41 四半期のうち 2 四半期を表示しています。 残る 39 四半期は 2016年10月 まで遡ります。